Literature DB >> 12820969

Modulation of NF-kappaB activity by exchange of dimers.

Simona Saccani1, Serafino Pantano, Gioacchino Natoli.   

Abstract

Transcription factors within a family usually share the ability to recognize similar or identical consensus sites. For example, the five mammalian NF-kappaB/Rel proteins generate more than 12 dimers recognizing 9-11 nucleotide kappaB sites. Each dimer selectively regulates a few target promoters; however, several genes are redundantly induced by more than one dimer. Whether this property simply generates redundancy in target gene activation or underlies more complex regulatory mechanisms is an open issue. We show here that during dendritic cell maturation, rapidly activated dimers (e.g., p50/RelA) bound to a subset of target promoters are gradually replaced by slowly activated dimers (e.g., p52/RelB). Since the dimers have different transcriptional activity at each promoter, the dimer exchange allows fine tuning of the response over time. Further, due to the insensitivity of p52/RelB to the NF-kappaB inhibitors, the IkappaBs, dimer exchange contributes to sustained activation of selected NF-kappaB targets in spite of the resynthesis of IkappaBalpha.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12820969     DOI: 10.1016/s1097-2765(03)00227-2

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  113 in total

1.  Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5.

Authors:  Xiang-Ping Yang; Kamran Ghoreschi; Scott M Steward-Tharp; Jaime Rodriguez-Canales; Jinfang Zhu; John R Grainger; Kiyoshi Hirahara; Hong-Wei Sun; Lai Wei; Golnaz Vahedi; Yuka Kanno; John J O'Shea; Arian Laurence
Journal:  Nat Immunol       Date:  2011-01-30       Impact factor: 25.606

2.  Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities.

Authors:  Alexander Hoffmann; Thomas H Leung; David Baltimore
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

Review 3.  Gene-specific epigenetic regulation in serious infections with systemic inflammation.

Authors:  Charles E McCall; Barbara Yoza; Tiefu Liu; Mohamed El Gazzar
Journal:  J Innate Immun       Date:  2010-04-27       Impact factor: 7.349

4.  An alternative to lung inflammation and fibrosis.

Authors:  Gilbert F Morris
Journal:  Am J Pathol       Date:  2010-04-22       Impact factor: 4.307

Review 5.  The nuclear factor NF-kappaB pathway in inflammation.

Authors:  Toby Lawrence
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-07       Impact factor: 10.005

Review 6.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

7.  The non-canonical NF-κB pathway is induced by cytokines in pancreatic beta cells and contributes to cell death and proinflammatory responses in vitro.

Authors:  Kira Meyerovich; Makiko Fukaya; Leticia F Terra; Fernanda Ortis; Decio L Eizirik; Alessandra K Cardozo
Journal:  Diabetologia       Date:  2015-12-03       Impact factor: 10.122

8.  The NF-κB genomic landscape in lymphoblastoid B cells.

Authors:  Bo Zhao; Luis A Barrera; Ina Ersing; Bradford Willox; Stefanie C S Schmidt; Hannah Greenfeld; Hufeng Zhou; Sarah B Mollo; Tommy T Shi; Kaoru Takasaki; Sizun Jiang; Ellen Cahir-McFarland; Manolis Kellis; Martha L Bulyk; Elliott Kieff; Benjamin E Gewurz
Journal:  Cell Rep       Date:  2014-08-21       Impact factor: 9.423

9.  RelA repression of RelB activity induces selective gene activation downstream of TNF receptors.

Authors:  Emilie Jacque; Thierry Tchenio; Guillaume Piton; Paul-Henri Romeo; Véronique Baud
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-28       Impact factor: 11.205

10.  Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide.

Authors:  Joerg Schreiber; Richard G Jenner; Heather L Murray; Georg K Gerber; David K Gifford; Richard A Young
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.